$1.36
+0.09 (+7.09%)
Open$1.28
Previous Close$1.27
Day High$1.39
Day Low$1.27
52W High$34.78
52W Low$20.23
Volume—
Avg Volume565.3K
Market Cap161.64M
P/E Ratio50.20
EPS$0.60
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+2,689.7% upside
Current
$1.36
$1.36
Target
$37.94
$37.94
$25.58
$37.94 avg
$45.71
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 60.16M | 53.18M | 50.95M |
| Net Income | -7,561,680 | -6,775,030 | -7,233,045 |
| Profit Margin | -12.6% | -12.7% | -14.2% |
| EBITDA | -8,587,792 | -7,436,735 | -8,070,839 |
| Free Cash Flow | -10,429,515 | -10,842,286 | -7,296,543 |
| Rev Growth | -4.1% | +12.5% | -5.7% |
| Debt/Equity | 1.23 | 1.43 | 1.23 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |